TWD 85.1
(8.41%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 728 Thousand TWD | -73.01% |
2022 | 2.69 Million TWD | 2964.77% |
2021 | 88 Thousand TWD | 20.55% |
2020 | 73 Thousand TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 345 Thousand TWD | 78.76% |
2023 FY | 728 Thousand TWD | -73.01% |
2023 Q4 | 193 Thousand TWD | -63.93% |
2023 Q2 | 535 Thousand TWD | -59.35% |
2022 Q4 | 1.31 Million TWD | 0.0% |
2022 FY | 2.69 Million TWD | 2964.77% |
2021 FY | 88 Thousand TWD | 20.55% |
2020 FY | 73 Thousand TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 99.935% |
Level Biotechnology Inc. | 660.61 Million TWD | 99.89% |
Sagittarius Life Science Corp | 440.46 Million TWD | 99.835% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | 98.875% |
TaiMed Biologics Inc. | 491.77 Million TWD | 99.852% |
GlycoNex Incorporation | 2.54 Million TWD | 71.361% |
VBI | 55.85 Million TWD | 98.697% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 99.677% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 99.77% |
Visgeneer Inc. | 147.99 Million TWD | 99.508% |
Mycenax Biotech Inc. | 652.62 Million TWD | 99.888% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 99.957% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 99.599% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 99.813% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 96.799% |
Enimmune corporation | 43.49 Million TWD | 98.326% |
TaiRx, Inc. | 5.08 Million TWD | 85.675% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 99.929% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 99.725% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 99.83% |
Lin BioScience, Inc. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 99.338% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 99.597% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | 39.735% |
Lukas Biomedical Inc. | 231.83 Million TWD | 99.686% |
RBC Bioscience Corporation | 172.46 Million TWD | 99.578% |
BiOptic Inc. | 228.26 Million TWD | 99.681% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -708.889% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | 92.356% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | 84.99% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 99.96% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | 96.395% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 99.816% |
Neith Corporation | 39.9 Million TWD | 98.176% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | 96.762% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 99.484% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | 9.565% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 99.909% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 98.721% |
AP Biosciences Inc | 32.25 Million TWD | 97.743% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 99.937% |
3D Global Biotech Inc. | 20.63 Million TWD | 96.472% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 99.769% |
Intech Biopharm Corporation | 25.84 Million TWD | 97.183% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | 99.161% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 99.904% |
TCI GENE Inc. | 333.85 Million TWD | 99.782% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -3944.444% |
Senhwa Biosciences, Inc. | 1 Million TWD | 27.2% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 99.148% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 99.545% |
PharmaEngine, Inc. | 767.66 Million TWD | 99.905% |
Savior Lifetec Corporation | 1.05 Billion TWD | 99.931% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 99.409% |
OBI Pharma, Inc. | 41.54 Million TWD | 98.248% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 99.689% |
Acepodia, Inc. | 16.59 Million TWD | 95.613% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | 98.13% |